BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/23/2024 4:32:16 AM | Browse: 39 | Download: 166
 |
Received |
|
2024-08-17 14:38 |
 |
Peer-Review Started |
|
2024-08-17 14:38 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-15 23:35 |
 |
Revised |
|
2024-09-24 09:45 |
 |
Second Decision |
|
2024-10-08 02:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-10-08 06:15 |
 |
Articles in Press |
|
2024-10-08 06:15 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-10-14 15:06 |
 |
Publish the Manuscript Online |
|
2024-10-23 04:32 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Pharmacology & Pharmacy |
Manuscript Type |
Letter to the Editor |
Article Title |
Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Xue-Juan Zhang, Xiao-Yi Jiang, Yi-Lin Ma, Fei-Yi Huang and Zheng-Wei Huang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
No. 82373800 |
Guangdong Basic and Applied Basic Research Foundation |
No. 2024A1515011236 |
General Program of Administration of Traditional Chinese Medicine of Guangdong Province |
No. 20241071 |
|
Corresponding Author |
Zheng-Wei Huang, PhD, Associate Professor, College of Pharmacy, Jinan University, No. 855 East Xingye Dadao, Panyu District, Guangzhou 511443, Guangdong Province, China. huangzhengw@jnu.edu.cn |
Key Words |
Taurin; Liposome; Liver fibrosis; Targeted therapy; Nanoparticle delivery systems; Hepatic stellate cells |
Core Tip |
Nanoparticle delivery systems are effective for delivering taurine (Tau). The nanoarchitecture of liposomes includes a water zone and a lipid membrane to accommodate hydrophilic and hydrophobic drugs, respectively. Tau is a hydrophilic molecule with high water solubility, and it is expected to be loaded into the water zone. In theory, hepatic stellate cells (HSCs) may be targeted by Tau-incorporated liposomes via two mechanisms: Passive targeting and active targeting. Active targeting is more robust as it takes advantage of the unique features of the lesion site. Based on a formulation for common liposomes (lecithin plus cholesterol), Tau-based therapeutics was proposed to treat liver fibrosis as follows: A targetable liposome was fabricated through the combination of common lecithin and cholesterol, along with modified lecithin or cholesterol with HSC targetability. Tau was dispersed into the water zone of this liposomal system. |
Publish Date |
2024-10-23 04:32 |
Citation |
<p>Zhang XJ, Jiang XY, Ma YL, Huang FY, Huang ZW. Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis. <i>World J Gastroenterol</i> 2024; 30(41): 4509-4513</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i41/4509.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i41.4509 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345